Bristol-Myers Squibb

Associate Director, Global Process Lead

Posted on: 20 Dec 2022

New Brunswick, New Jersey | Princeton, NJ

Job Description

Job Description

Working with Us

Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us

The Global Process Lead (GPL) for Commercial Change Management (CCM) will ensure the Commercial process remains in a state of control and is both effective and efficient serving as the key point of contact for CCM providing customer-based cross functional support.

Key Responsibilities:

Drive ongoing process optimization and improvement following standard methodology.

Develop and maintain global processes, procedural document, and training materials in compliance with Global GxP requirements, BMS Global Quality Standards, and BMS’ Quality Management System (QMS) principles of integrated, patient-centric, and risk-based decision-making.

Participate (or lead when delegated) in regulatory surveillance and benchmarking initiatives with peers internally and externally to stay abreast of changes in regulations that affect impacted processes and also to identify new ways of working and evolving technologies in this space.

Work with the Global Process Owner (GPO) and LPO’s (Local Process Leads) to define process monitoring methods, including data collection and analysis, metrics, and associated targets, and reporting mechanisms including both product/clinical trial quality and process effectiveness aspects.

Regularly review process performance and effectiveness of the Commercial Change Management process and provide feedback to the GPO and CCM Community of Practice (CoP) for action and remediation.

Identify and prioritize continuous improvement opportunities for the process.

Lead problem solving and continuous improvement efforts working effectively across the matrix by engaging with the broader process owner network, local site or function process owners (LPOs), and Subject Matter Experts (SME) in designing and deploying QMS process improvements. 

Ensure continuity of process and support systems through major initiatives (e.g. integration, divestiture, or reorganization); serve/lead program teams or sub-teams, manage interim state of operations and ensure establishment of defined future state of processes, as applicable).

Provide training, support, and coaching as required to support deployment of the global CCM Process.

Key Requirements:

A minimum of a Bachelor’s degree preferably in Life Sciences

A minimum of 10 years’ experience in biological sciences or equivalent

A minimum of 8 years’ experience and in-depth knowledge of managing/performing GxP change management activities

Strong understanding of cGxPs and in-depth knowledge of quality systems principles and applications

In depth experience in change management processes and the regulations governing change management

Cross-functional experience including experience in Pharmaceutical or BioPharma manufacturing operations

Demonstrated influential leadership expertise and experience with senior level interactions

Capability to build alignment with business partners including research & development, commercial operations and manufacturing regional and site leaders

Enterprise mindset to be able to think and act across functions and divisions

Demonstrated change agility in anticipating and leading others through change and ambiguity

Demonstrated ability to work in a matrixed organization with a range of technically, culturally, and geographically diverse teams and to influence areas not under direct control to achieve objectives and effectively communicate challenging goals and objective

#LI-Hybrid

Bristol-Myers Squibb

New York, New York

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company’s products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.

It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. It has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; and FameWave Ltd.

The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.

  • Industry
    Biopharmaceuticals
  • No. of Employees
    23, 300
  • Jobs Posted
    1641

Similar Jobs